-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Reiterates Buy on Surgery Partners, Maintains $19 Price Target

Benzinga·09/18/2026 15:04:35
语音播报
TD Cowen analyst Ryan Langston reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $19 price target.